An observational study in Nocturia, sponsored by University Hospital, Ghent. Recruiting at 1 site in Belgium. Open to female participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-12.
Sponsored by University Hospital, Ghent · Observational
Aim of this study was to observe
The study was adjusted in two parts:
PART 1 is a crossectional study in which the prevalance, risk factors and etiology of nocturia among postmenopausal women is assessed.
PART 2 is a cohort study observing the impact of 10 different hormonal substitution therapies on nocturia.
134 studies on the registry are indexed under Nocturia; 22 are open to participants now.
This study's planned enrollment of 300 is above the median of 150 across 21 observational studies indexed under Nocturia.
Browse Nocturia studies →University Hospital, Ghent is the lead sponsor of 689 studies on the registry; 160 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women who are biochochemically confirmed to be postmenopausal.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Women who opt to be treated for their postmenopausal symptoms using Oral estrogen + IUD
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using Oral estrogen + hysterectomy.
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using Oral estrogen + oral progesterone.
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using transdermal estrogen + IUD.
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using transdermal estrogen + hysterectomy.
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using transdermal estrogen + oral progesteron
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using SERM's
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using aromatase inhibitor.
Other: Questionnaire
Women who opt to be treated for their postmenopausal symptoms using duavive.
Other: Questionnaire
Women who opt not to be treated for their postmenopausal symptoms.
Other: Questionnaire
All women fulfilled 3 questionairres * TANGO * ICIQ -N * Perceived Stress Scale
Change in nocturnal Frequency
Change from baseline in nocturnal voiding episodes assessed via nycturia and menopause questionnaire
Time frame: 6 months after initiating therapy
Change in bother linked with nocturnal frequency
Change in VAS scale of bother linked with nocturnal frequency
Time frame: 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jun 2018 (actual). Primary completion is estimated for Dec 2025, 90 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.